Search Within

Gary Schwartz

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (25)
Groups
  1. Department of Medicine (64)
  2. Sarcoma Service (64)
  3. Solid Tumor Oncology Division (64)
  4. GSK Faculty (29)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. Mark Dickson (40)
  2. Richard Carvajal (26)
  3. William Tap (26)
  4. Mary Keohan (21)
  5. Sandra D'Angelo (20)
  6. Cristina Antonescu (16)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2015 (2)
  4. 2014 (7)
  5. 2013 (20)
  6. 2012 (13)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Clinical Cancer Research (4)
  3. Cancer Research (3)
  4. British Journal of Cancer (2)
  5. Sarcoma (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (8)
  3. Wiley Blackwell (3)
  4. Hindawi Publishing Corporation (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoma immunotherapy: Past approaches and future directions
    Journal Article

    D'Angelo, S. P.; Tap, W. D.; Schwartz, G. K.; Carvajal, R. D.
    Sarcoma (2014)

    Fulltext@MSK | Save
  • A phase Ib/II study of imatinab and everolimus in patients with PDGFRA plus synovial sarcoma
    Meeting Abstract

    Keohan, M. L.; Tap, W. D.; Dickson, M. A.; D'Angelo, S. P.; Carvajal, R. D.; Gounder, M. M.; Morales, R. E.; Condy, M. M.; Hameed, M.; Ho, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Alliance A091102: Phase II study of MLN8237 (alisertib) in advanced/metastatic sarcoma
    Meeting Abstract

    Dickson, M. A.; Mahoney, M. R.; Marchello, B. I. T.; Condy, M.; Tap, W. D.; Schwartz, G. K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Alliance A091103: Multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib for the treatment of angiosarcoma
    Meeting Abstract

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Poor prognostic features in angiosarcoma: A single institution retrospective study of 324 patients
    Meeting Abstract

    D'Angelo, S. P.; Moraco, N. H.; Qin, L. X.; Kuk, D.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Antonescu, C. R.; Singer, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)
    Meeting Abstract

    Carvajal, R. D.; Sosman, J. A.; Quevedo, F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T.; Lutzky, J.; Lawson, D. H.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma
    Meeting Abstract

    Patwardhan, P.; Deraje Vasudeva, S.; Tap, W. D.; de Stanchina, E.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save